Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
3.64M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.29M
-
Shares change
-
+25.9K
-
Total reported value, excl. options
-
$3.87M
-
Value change
-
+$78.1K
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$3.01
Significant Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) as of Q1 2025
19 filings reported holding KPRX - KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value as of Q1 2025.
KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.29M shares
of 3.64M outstanding shares and own 35.31% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (254K shares), Rosalind Advisors, Inc. (250K shares), Nantahala Capital Management, LLC (211K shares), Stonepine Capital Management, LLC (201K shares), ADAR1 Capital Management, LLC (195K shares), Velan Capital Investment Management LP (122K shares), CITADEL ADVISORS LLC (26.6K shares), GEODE CAPITAL MANAGEMENT, LLC (18.3K shares), SABBY MANAGEMENT, LLC (5K shares), and Tower Research Capital LLC (TRC) (2.19K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.